medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2013, Number 1

<< Back Next >>

Ann Hepatol 2013; 12 (1)

Spondias pinnata stem bark extract lessens iron overloaded liver toxicity due to hemosiderosis in Swiss albino mice

Hazra B, Sarkar R, Mandal N

Language: English
References: 35
Page: 123-129
PDF size: 183.85 Kb.


ABSTRACT

The present study was designed to evaluate the ameliorating effect of 70% methanol extract of Spondias pinnata (SPME) on iron overload induced liver injury. Iron overload was induced by intraperitoneal administration of iron-dextran into mice and resulting liver damage was manifested by significant rise in serum enzyme markers (ALT, AST, ALP and bilirubin) and reduction in liver antioxidants (SOD, CAT, GST and GSH). Hepatic iron, serum ferritin, lipid peroxidation, protein carbonyl and hydroxyproline contents were measured in response to the oral administration of SPME of different doses (50, 100 and 200 mg/kg body weight). In order to determine the efficiency as iron chelating drug, the release of iron from ferritin by SPME was further studied. Enhanced levels of antioxidant enzymes were detected in SPME treated mice. SPME produced a dose dependent inhibition of lipid peroxidation, protein oxidation, liver fibrosis; and levels of serum enzyme markers and ferritin were also reduced dose dependently. The liver iron content was also found to be less in SPME treated group compared to control group. The reductive release of ferritin iron was augmented significantly after dose dependent addition of SPME. The ameliorating effect of SPME on damaged liver was furthermore supported by the histopathological studies that showed improved histological appearances. In conclusion, the present results demonstrate the hepatoprotective efficiency of SPME in iron intoxicated mice, and hence possibly useful as iron chelating drug for iron overload diseases.


REFERENCES

  1. Anusha M, Venkateswarlu M, Prabhakaran V, Taj SS, Kumari BP, Ranganayakulu D. Hepatoprotective activity of aqueous extract of Portulacaoleracea in combination with lycopene in rats. Indian J Pharmacol 2011; 43: 563-67.

  2. Bothwell TH, Charlton RW, Cook JD, Finch CA. Iron Metabolism in Man. Oxford: Blackwell Scientific Publishers; 1979.

  3. Deugnier YM, Loreal O, Turlin B, Guyader D, Jouanolle H, Moirand R, Jacquelinet C, et al. Liver pathology in genetic hemochromotosis: a review of 135 hemozygouscases and their bioclinical correlations. Gastroenterology 1992; 102: 2050-9.

  4. Adams PC. Hemochromatosis: New Insights in Pathogenesis and Diagnosis Following the Discovery of the Gene. Crit Rev Cl Lab Sci 1998; 35(3): 239-73.

  5. Risdon RA, Barry M, Flynn DM. Transfusional iron overload: the relationship between tissue iron concentration and hepatic fibrosis in thalassaemia. J Pathol 1975; 116: 83-95.

  6. McLaren CE, Gordeuk VR, Looker AC, Hasselblad V, Edwards CQ, Griffen LM, Kushner JP, et al. Prevalence of heterozygotes for hemochromatosis in the white population of the United States. Blood 1995; 86: 2021-7.

  7. Bacon BR, Britton RS. The pathology of hepatic iron overload, a free radical mediated process? Hepatology 1990; 11: 127-37.

  8. Bomford A, Williams R. Long term result of venesection therapy in idiopathic hemochromatosis. Q J Med 1976; 45: 611-23.

  9. Cappellini MD, Taher A. Deferasirox (Exjade) for the treatment of iron overload. Acta Haematol 2009; 122: 165-73.

  10. Cohen AR. Iron chelation therapy: you gotta have heart. Blood 2010; 115: 2333-4.

  11. Richardson DR. The therapeutic potential of iron chelators. Expert Opin Investig Drugs 1999; 8: 2141-58.

  12. Pardo-Andreu GL, Barrios MF, Curti C, Hernandez I, Merino N, Lemus Y, Martínez I, et al. Protective effects of Mangifera indicaL extract (Vimang), and its major component mangiferin, on iron-induced oxidative damage to rat serum and liver. Pharmacol Res 2008; 57: 79-86.

  13. Dikshit P, Tyagi MK, Shukla K, Sharma S, Gambhir JK, Shukla R. Hepatoprotective effect of stem of Musa sapientum Linn. in rats intoxicated with carbon tetrachloride. Ann Hepatol 2011; 10: 333-9.

  14. Morel I, Lascoat G, Cogerel P, Sergent O, Pasdeloup N, Brissot P, Cillard P, et al. Antioxidant and iron-chelating activity of the flavonoids catechen, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. Biochem Pharmacol 1993; 45: 13-9.

  15. López M, Martínez F, Del Valle C, Ferrit M, Luque R. Study of phenolic compounds as natural antioxidants by a fluorescence method. Talanta 2003; 60: 609-16.

  16. Cook NC, Samman S. Flavonoids-chemistry, metabolism, cardioprotective effects, and dietary sources. J Nutr Biochem 1996; 7: 66-76.

  17. Hazra B, Biswas S, Mandal N. Antioxidant and free radical scavenging activity of Spondias pinnata. BMC Complement Altern Med 2008; 8: 63.

  18. Lowry OH, Roesborough MJ, Farr AL, Randall RJ. Protein measurement with Folin-Phenol reagent. J Biol Chem 1951; 193: 265-75.

  19. Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 1984; 21: 130-2.

  20. Bonaventura J, Schroeder WA, Fang S. Human erythrocyte catalase: an improved method of isolation and a re-evaluation of reported properties. Arch Biochem Biophys 1972; 150: 606-17.

  21. Habig WH, Pabst MJ, Jakoby WB. Glutathione S transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974; 249: 7130-9.

  22. Ellman GL. Tissue sulfhydryl group. Arch Biochem Biophys 1959; 82: 70-7.

  23. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978; 52: 302-10.

  24. Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 1994; 233: 357-63.

  25. Bergman I, Loxley R. Two improved and simplified methods for the spectrophotometric determination of hydroxyproline. Anal Chem 1962; 35: 1961-5.

  26. Kivirikko KI, Laitinen O, Prockop DJ. Modifications of a specific assay for hydroxyproline in urine. Anal Biochem 1967; 19: 249-55.

  27. Barry M, Sherlock S. Measurement of liver-iron concentration in needle biopsy specimens. Lancet 1971; 297: 100-3.

  28. Hynes MJ, Coinceanainn M. Investigation of the release of iron from ferritin by naturally occurring antioxidants. J Biol Chem 2002; 90: 18-21.

  29. Bonkovsky HL. Iron and the liver. Am J Med Sci 1991; 301: 32-43.

  30. Galleano M, Simontacchi M, Puntarulo S. Nitric oxide and iron: effect of iron overload on nitric oxide production in endotoxemia. Mol Aspects Med 2004; 25: 141-54.

  31. Pulla Reddy A, Lokesh BR. Effect of curcumin and eugenol on iron-induced hepatic toxicities in rats. Toxicology 1996; 107: 39-45.

  32. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev 1998; 78: 547-81.

  33. Bonkovsky HL, Healey JF, Sinclair PR, Sinclair JF, Pomeroy JS. Iron and the liver. Acute and long-term effects of ironloading on hepatic haem metabolism. Biochem J 1981; 196: 57-64.

  34. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as a biomarkers of oxidative stress. Clin Chim Acta 2003; 329: 23-8.

  35. Harrison PM. Ferritin: an iron-storage molecule. Sem Hematol 1977; 14: 55-70.




2020     |     www.medigraphic.com